2015
DOI: 10.1016/j.ijcard.2015.01.044
|View full text |Cite
|
Sign up to set email alerts
|

Late differences in outcomes of patients with stable angina and an isolated lesion in the proximal left anterior descending artery treated with new-generation drug-eluting stents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 24 publications
0
5
0
Order By: Relevance
“…We conducted a cross-sectional survey between October 2017 and January 2018, with 342 consecutive outpatients with stable angina from the outpatient Department of Cardiology at the Second Affiliated Hospital of Army Medical University, Chongqing, China. According to a previous definition [11, 12], patients with chronic stable angina and/or ischemia, as demonstrated via stress tests, exhibited stenosis of any diameter greater than 70% in at least one epicardial vessel. The exclusion criteria included lesions in the left main coronary artery; multivessel disease; acute coronary syndrome; and previous myocardial infarction, percutaneous coronary intervention, or coronary artery bypass grafting.…”
Section: Methodsmentioning
confidence: 99%
“…We conducted a cross-sectional survey between October 2017 and January 2018, with 342 consecutive outpatients with stable angina from the outpatient Department of Cardiology at the Second Affiliated Hospital of Army Medical University, Chongqing, China. According to a previous definition [11, 12], patients with chronic stable angina and/or ischemia, as demonstrated via stress tests, exhibited stenosis of any diameter greater than 70% in at least one epicardial vessel. The exclusion criteria included lesions in the left main coronary artery; multivessel disease; acute coronary syndrome; and previous myocardial infarction, percutaneous coronary intervention, or coronary artery bypass grafting.…”
Section: Methodsmentioning
confidence: 99%
“…Endeavor-Sprint-ZES (29.5%) were included along with the EES in the DES-PCI group. Previous nonrandomized trials have shown that EES had better results, especially for target lesion revascularization, than the Endeavor-Sprint ZES [23][24][25][26][27] ; however, a subanalysis com-…”
Section: Discussionmentioning
confidence: 93%
“…Endeavor‐Sprint‐ZES (29.5%) were included along with the EES in the DES‐PCI group. Previous nonrandomized trials have shown that EES had better results, especially for target lesion revascularization, than the Endeavor‐Sprint ZES 23‐27 ; however, a subanalysis comparing EES‐PCI with CABG was not conducted in the current study due to potentially inadequate power because of the limited sample size. Although we adjusted for several possible or known factors that may affect our results, other factors, such as, medication at discharge might have affected our results.…”
Section: Discussionmentioning
confidence: 98%
“…The use of new-generation of DES have shown much less rate of restenosis, giving opportunities for cure even in case of high-risk lesions such as ostial lesions 32 . Since there are still difference for each new generation of DES in terms of clinical outcomes 33 , there might be further chances to develop a new candidate drug for DES. Many drugs such as paclitaxel, sirolimus, and zotarolimus could be toxic to human body if adequate concentration of each oral drug for anti-proliferative effect should be reached.…”
Section: Discussionmentioning
confidence: 99%